... for their work on a proposed settlement in a derivative suit against CytRx Corp. directors in connection with a stock-pumping scheme, telling a Delaware state ...
... pipeline with excellent bioequivalence studies such as AT-0918 (Cytori Therapeutics, Inc.). Aldoxorubicin (CytRx Corporation) utilizes acid sensitive linker that selectively binds to albumin to allow ...
... York (November 20, 2017, 3:08 PM EST) -- Investors suing biopharmaceutical company CytRx Corp. for allegedly misrepresenting the success of a late-stage trial of a ...